Curcumin is a group of yellow pigments found in turmeric (Curcuma longa). Claims about the health benefits of turmeric often blur food and medicine. Turmeric powder is a culinary spice containing a relatively small and variable amount of curcuminoids, while a curcumin supplement may provide a concentrated extract or an enhanced-absorption formulation. They are not interchangeable.
The most relevant human evidence concerns short-term symptoms of knee osteoarthritis. Reviews report small average improvements in pain or function, but confidence is limited by varied products, small trials and possible bias. Curcumin has not been shown to rebuild cartilage or cure arthritis.
Laboratory studies describe antioxidant and anti-inflammatory effects of curcumin, but a change in a biomarker is not proof that a supplement prevents or treats disease. Curcumin should not replace prescribed treatment for rheumatoid arthritis, diabetes, cancer, depression or another condition.
Australian regulators also require a liver-injury warning on oral medicines containing curcumin as an active ingredient. Food amounts of turmeric have not raised the same signal. The safe choice depends on the exact product, medicines, health history and reason for use, not on a universal daily dose.
Written by: Charles Gumbley, BHSc Clinical Nutrition, DipHSc Western Herbal Medicine. Evidence checked: 20 July 2026.
Turmeric and Curcumin Are Different Products
Turmeric root contains curcuminoids, essential oils, starch and other constituents. Curcumin is one curcuminoid and is often standardised with related compounds in a turmeric extract. Taking turmeric as a food is not equivalent to taking an extract. The amount obtained from a meal cannot be inferred from the milligrams printed on a dietary supplement.
Unformulated oral curcumin is poorly absorbed and is rapidly metabolised. The absorption of curcumin and its bioavailability depend on the delivery system. Manufacturers may combine it with piperine from black pepper, lipids, phospholipids, micelles or nanoparticles to increase exposure. That means 500 mg in one product cannot be assumed equivalent to the same labelled amount in another curcumin formulation.
Greater bioavailability is not automatically better. It can change adverse effects and interaction risk. The safety of curcumin therefore cannot be judged from the front-label milligram number alone. The Therapeutic Goods Administration (TGA) says the rare liver-injury risk may be higher with enhanced absorption or higher doses, although the agency could not identify every higher-risk medicine. Formulation details matter when comparing curcumin supplements.
Health Benefits of Curcumin for Osteoarthritis
A 2025 network meta-analysis of 17 studies found that several turmeric preparations reduced knee osteoarthritis pain compared with placebo. However, the certainty of evidence was low. A 2024 umbrella analysis of prior meta-analyses also reported improvements in osteoarthritis pain, stiffness and function, while highlighting variation and limitations in the underlying trials.
This supports a cautious conclusion: curcumin may help some people achieve a modest reduction in knee osteoarthritis symptoms over the studied period. It does not establish long-term safety, disease modification or one superior product. Exercise, weight management when relevant, physiotherapy and appropriate medicines have broader clinical roles and should not be displaced.
Curcumin Supplementation and Rheumatoid Arthritis
Evidence for rheumatoid arthritis is less certain. A 2023 review of dietary polyphenol trials reported possible improvements in some inflammatory and clinical measures, but studies used different compounds and methods. Curcumin treatment is not an alternative to disease-modifying antirheumatic medicines, which prevent joint damage.
Effect of Curcumin on Inflammation and Metabolic Markers
Curcumin can affect signalling pathways in cells, which helps explain research interest in its potential health benefits. Any anti-inflammatory effect in a laboratory model must still be tested in people. A 2024 meta-analysis of 103 randomised trials pooled 42 outcomes and reported statistically significant changes in several blood glucose, lipid, inflammatory and oxidative markers. Many other outcomes had low or very-low certainty, and the authors called for larger, longer, well-designed trials.
These findings do not mean oral curcumin supplementation treats diabetes or cardiovascular disease. Surrogate markers such as C-reactive protein are not the same as fewer heart attacks, less disability or longer survival. People using glucose-lowering, blood-pressure or other prescribed medicines should not add curcumin to chase a laboratory result without professional advice.
Claims about cancer prevention or treatment are especially inappropriate. Cell and animal experiments cannot establish benefit in people, and concentrated supplements may interact with cancer medicines. Discuss every supplement with the oncology team.
Curcumin Supplements: Liver Warning and Adverse Effects
In Australia, the in-force Therapeutic Goods (Permissible Ingredients) Determination requires oral medicines with curcumin as an active ingredient to carry this warning: in very rare cases curcumin may harm the liver, and users should stop and see a doctor for specified symptoms. High doses of curcumin and enhanced-absorption products warrant particular caution.
Stop the product and seek prompt medical advice for yellow skin or eyes, dark urine, unusual fatigue, nausea, appetite loss, abdominal pain or itching. The TGA advises people with current or previous liver problems to avoid medicinal turmeric and curcumin products. Typical dietary amounts used as food have not been linked to this signal.
Other adverse effects can include nausea, reflux, abdominal discomfort or diarrhoea. Turmeric supplements may be unsuitable with gallstones or bile-duct obstruction. Curcumin may affect platelet function and drug metabolism, so check with a pharmacist before use with anticoagulants, antiplatelet medicines, diabetes medicines or other regular treatment. Stop before surgery only according to the surgical team’s instructions.
Safety data are insufficient for unsupervised concentrated use during pregnancy, breastfeeding or childhood. The 2026 Determination prohibits curcumin active-ingredient oral medicines in children under two and imposes age-based curcumin limits for older children; a child should use one only on qualified advice.
Choosing a Turmeric Supplement Safely
Start with the purpose. “General inflammation” is too vague to judge benefit, dose or duration. For osteoarthritis, confirm the diagnosis and consider treatments with established benefit before deciding whether a time-limited supplement trial is reasonable.
Use of Curcumin: Dose and Product Selection
Check the ARTG number and match the listed ingredient, curcuminoid amount, full daily dose, formulation, piperine and warning label. An ARTG listing does not mean the TGA has independently proven every advertised benefit or the safety and efficacy of curcumin for every use. Do not copy a dose of curcumin from a trial unless the product and population genuinely match.
Avoid stacking several products containing turmeric, curcumin or black pepper extract. Record the brand, batch, start date and symptoms, and agree on a review point. Stop if there is no worthwhile improvement or if an adverse effect occurs. Report suspected medicine reactions to the TGA.
Nutrition Market sells turmeric and curcumin products, creating a commercial conflict. No product is ranked or linked in this article until its current formula, curcuminoid exposure, absorption technology, mandatory warning, ARTG claims, interactions, stock, cost and margin pass the governed feed rules.
Curcumin Benefits: Common Questions
What happens when you take curcumin every day?
There is no single outcome. Some people experience no noticeable change; some trials report modest short-term osteoarthritis symptom improvement; others develop gastrointestinal effects. Very rare liver injury can be severe. Daily use should have a defined reason, compatible formulation and medicines, and a review date.
What is better, turmeric or curcumin?
Neither is universally better. Turmeric is useful as a food spice. A standardised curcumin or turmeric extract provides a more concentrated and measurable exposure for research, but concentration and enhanced absorption can also increase risk. Choose according to purpose and safety, not potency alone.
What are the benefits of taking curcumin?
The most credible clinical signal is a possible small reduction in knee osteoarthritis pain or stiffness with certain preparations. Research reports changes in some inflammatory and metabolic markers, but this does not establish treatment or prevention of chronic disease. Benefits depend on formulation and indication.
What are the disadvantages of curcumin?
Disadvantages include uncertain product equivalence, limited long-term evidence, gastrointestinal effects, medicine interactions and a very rare risk of serious liver injury. Concentrated products may be unsuitable with liver or biliary disease, pregnancy, breastfeeding, childhood, bleeding risk or surgery.
Curcumin and Turmeric: Evidence and References
- Khayat S, et al. Effect of turmeric products on knee osteoarthritis: a systematic review and network meta-analysis. BMC Complementary Medicine and Therapies. 2025;25:270. PMID 40731001. doi:10.1186/s12906-025-05045-z.
- Zeng L, et al. The efficacy of curcumin in relieving osteoarthritis: a meta-analysis of meta-analyses. Phytotherapy Research. 2024;38(6):3054–3067. PMID 38576215. doi:10.1002/ptr.8153.
- Jafari A, et al. Curcumin on human health: a systematic review and meta-analysis of 103 randomised controlled trials. Phytotherapy Research. 2024;38(12):6048–6061. PMID 39478418. doi:10.1002/ptr.8340.
- Lee YH, et al. Efficacy and safety of dietary polyphenols in rheumatoid arthritis: a systematic review and meta-analysis of 47 randomised controlled trials. Frontiers in Immunology. 2023;14:1024120. PMID 37033930. doi:10.3389/fimmu.2023.1024120.
- Therapeutic Goods Administration. Medicines containing turmeric or curcumin: risk of liver injury. Published 15 August 2023; accessed 20 July 2026.
- Australian Government. Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2026. In force from 11 June 2026; accessed 20 July 2026.
This article provides general educational information, not personalised medical advice. Seek medical care for possible liver injury, severe symptoms or a hot, swollen joint; do not stop prescribed arthritis or other treatment without advice.
